Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

MediPharm Taps Cannabis Veterans for Key Roles

Stockhouse Editorial
0 Comments| October 19, 2018

Licensed cannabis producer MediPharm Labs Inc (TSX: V.LABS , Forum) on Friday announced that pharmaceutical industry veteran David Mayers has been brought on as the Company’s Chief Operating Officer, while top cannabis compliance professional Anuja Siwakoti has been appointed as the Company’s Director of Global Regulatory and Scientific Affairs.

For more on this news, click here.

Last week, MediPharm entered into a Cannabis Concentrate Program Agreement with Emerald Health Therapeutics Inc. (TSXV: EMH) where LABS will receive dried cannabis to create premium quality cannabis oil over a three-year term.

FULL DISCLOSURE: MediPharm Labs Inc. is a paid client of Stockhouse Publishing.

Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Metals & Mining

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.


No comments yet. Be first to comment!

Leave a Comment

You must be logged in to access this feature.


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.